vs

Side-by-side financial comparison of NEOGENOMICS INC (NEO) and ORMAT TECHNOLOGIES, INC. (ORA). Click either name above to swap in a different company.

ORMAT TECHNOLOGIES, INC. is the larger business by last-quarter revenue ($276.0M vs $186.7M, roughly 1.5× NEOGENOMICS INC). ORMAT TECHNOLOGIES, INC. runs the higher net margin — 11.4% vs -57.9%, a 69.2% gap on every dollar of revenue. On growth, ORMAT TECHNOLOGIES, INC. posted the faster year-over-year revenue change (19.6% vs 11.1%). Over the past eight quarters, ORMAT TECHNOLOGIES, INC.'s revenue compounded faster (11.0% CAGR vs 6.5%).

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

Ormat Technologies, Inc. is an international company based in Reno, Nevada, United States. Ormat supplies alternative and renewable geothermal energy technology. The company has built over 190 power plants and installed over 3,200 MW of output. As of January 2021 it owns and operates 933 MW of geothermal and recovered energy based power plants. Ormat has supplied over 1000 turbochargers worldwide, in North America, South America, Europe, Australia, and Asia. The company's products also includ...

NEO vs ORA — Head-to-Head

Bigger by revenue
ORA
ORA
1.5× larger
ORA
$276.0M
$186.7M
NEO
Growing faster (revenue YoY)
ORA
ORA
+8.5% gap
ORA
19.6%
11.1%
NEO
Higher net margin
ORA
ORA
69.2% more per $
ORA
11.4%
-57.9%
NEO
Faster 2-yr revenue CAGR
ORA
ORA
Annualised
ORA
11.0%
6.5%
NEO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
NEO
NEO
ORA
ORA
Revenue
$186.7M
$276.0M
Net Profit
$-108.0M
$31.4M
Gross Margin
43.3%
28.6%
Operating Margin
46.9%
15.4%
Net Margin
-57.9%
11.4%
Revenue YoY
11.1%
19.6%
Net Profit YoY
42.0%
-23.2%
EPS (diluted)
$-0.13
$0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NEO
NEO
ORA
ORA
Q1 26
$186.7M
Q4 25
$190.2M
$276.0M
Q3 25
$187.8M
$249.7M
Q2 25
$181.3M
$234.0M
Q1 25
$168.0M
$229.8M
Q4 24
$172.0M
$230.7M
Q3 24
$167.8M
$211.8M
Q2 24
$164.5M
$213.0M
Net Profit
NEO
NEO
ORA
ORA
Q1 26
$-108.0M
Q4 25
$31.4M
Q3 25
$-27.1M
$24.1M
Q2 25
$-45.1M
$28.0M
Q1 25
$-25.9M
$40.4M
Q4 24
$40.8M
Q3 24
$-17.7M
$22.1M
Q2 24
$-18.6M
$22.2M
Gross Margin
NEO
NEO
ORA
ORA
Q1 26
43.3%
Q4 25
43.8%
28.6%
Q3 25
42.8%
25.6%
Q2 25
42.6%
24.3%
Q1 25
43.6%
31.7%
Q4 24
44.9%
31.9%
Q3 24
44.6%
27.8%
Q2 24
44.1%
28.8%
Operating Margin
NEO
NEO
ORA
ORA
Q1 26
46.9%
Q4 25
-7.1%
15.4%
Q3 25
-14.4%
16.2%
Q2 25
-26.3%
15.1%
Q1 25
-16.6%
22.2%
Q4 24
-10.7%
21.3%
Q3 24
-12.6%
16.8%
Q2 24
-13.3%
16.5%
Net Margin
NEO
NEO
ORA
ORA
Q1 26
-57.9%
Q4 25
11.4%
Q3 25
-14.4%
9.7%
Q2 25
-24.9%
12.0%
Q1 25
-15.4%
17.6%
Q4 24
17.7%
Q3 24
-10.5%
10.4%
Q2 24
-11.3%
10.4%
EPS (diluted)
NEO
NEO
ORA
ORA
Q1 26
$-0.13
Q4 25
$0.51
Q3 25
$0.39
Q2 25
$0.46
Q1 25
$0.66
Q4 24
$0.67
Q3 24
$0.36
Q2 24
$0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NEO
NEO
ORA
ORA
Cash + ST InvestmentsLiquidity on hand
$146.1M
$147.4M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$828.8M
$2.5B
Total Assets
$1.3B
$6.2B
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NEO
NEO
ORA
ORA
Q1 26
$146.1M
Q4 25
$159.6M
$147.4M
Q3 25
$164.1M
$79.6M
Q2 25
$154.7M
$88.5M
Q1 25
$346.2M
$112.7M
Q4 24
$367.0M
$94.4M
Q3 24
$362.0M
$88.1M
Q2 24
$355.1M
$66.3M
Total Debt
NEO
NEO
ORA
ORA
Q1 26
Q4 25
$341.9M
$2.7B
Q3 25
Q2 25
Q1 25
Q4 24
$541.1M
$2.3B
Q3 24
Q2 24
Stockholders' Equity
NEO
NEO
ORA
ORA
Q1 26
$828.8M
Q4 25
$836.6M
$2.5B
Q3 25
$838.3M
$2.5B
Q2 25
$854.0M
$2.5B
Q1 25
$888.3M
$2.5B
Q4 24
$902.3M
$2.4B
Q3 24
$908.2M
$2.4B
Q2 24
$915.9M
$2.4B
Total Assets
NEO
NEO
ORA
ORA
Q1 26
$1.3B
Q4 25
$1.4B
$6.2B
Q3 25
$1.4B
$6.1B
Q2 25
$1.4B
$6.0B
Q1 25
$1.6B
$5.8B
Q4 24
$1.6B
$5.7B
Q3 24
$1.6B
$5.6B
Q2 24
$1.6B
$5.5B
Debt / Equity
NEO
NEO
ORA
ORA
Q1 26
Q4 25
0.41×
1.05×
Q3 25
Q2 25
Q1 25
Q4 24
0.60×
0.97×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NEO
NEO
ORA
ORA
Operating Cash FlowLast quarter
$-8.1M
$105.0M
Free Cash FlowOCF − Capex
$-40.0M
FCF MarginFCF / Revenue
-14.5%
Capex IntensityCapex / Revenue
52.6%
Cash ConversionOCF / Net Profit
3.35×
TTM Free Cash FlowTrailing 4 quarters
$-284.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NEO
NEO
ORA
ORA
Q1 26
$-8.1M
Q4 25
$1.3M
$105.0M
Q3 25
$8.9M
$45.2M
Q2 25
$20.3M
$96.9M
Q1 25
$-25.3M
$88.0M
Q4 24
$9.8M
$158.6M
Q3 24
$9.2M
$106.4M
Q2 24
$13.9M
$30.7M
Free Cash Flow
NEO
NEO
ORA
ORA
Q1 26
Q4 25
$-6.5M
$-40.0M
Q3 25
$570.0K
$-102.1M
Q2 25
$14.0M
$-37.9M
Q1 25
$-29.8M
$-104.6M
Q4 24
$-1.8M
$30.9M
Q3 24
$-1.6M
$-3.3M
Q2 24
$814.0K
$-116.1M
FCF Margin
NEO
NEO
ORA
ORA
Q1 26
Q4 25
-3.4%
-14.5%
Q3 25
0.3%
-40.9%
Q2 25
7.7%
-16.2%
Q1 25
-17.8%
-45.5%
Q4 24
-1.0%
13.4%
Q3 24
-0.9%
-1.6%
Q2 24
0.5%
-54.5%
Capex Intensity
NEO
NEO
ORA
ORA
Q1 26
Q4 25
4.1%
52.6%
Q3 25
4.4%
59.0%
Q2 25
3.5%
57.6%
Q1 25
2.7%
83.8%
Q4 24
6.7%
55.4%
Q3 24
6.4%
51.8%
Q2 24
8.0%
69.0%
Cash Conversion
NEO
NEO
ORA
ORA
Q1 26
Q4 25
3.35×
Q3 25
1.87×
Q2 25
3.45×
Q1 25
2.18×
Q4 24
3.89×
Q3 24
4.82×
Q2 24
1.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NEO
NEO

Segment breakdown not available.

ORA
ORA

Electricity$186.6M68%
Products$63.1M23%
Energy Storage Segment$26.3M10%
Product Segment$1.2M0%

Related Comparisons